Skip to main content
Created by potrace 1.11, written by Peter Selinger 2001-2013
NO
Search oslomet.no
  • About OsloMet
  • Study at OsloMet
  • Our research
  • Work for us
  • Alumni
  • University Library
  • Contact us
  1. OsloMet
  2. ...Intermediate levels are hidden
  3. Research news
  4. A simple brain test can detect early signs of Alzheimer’s

A simple brain test can detect early signs of Alzheimer’s

A routine brain test already available in many hospitals, combined with artificial intelligence, can detect early signs of Alzheimer’s disease — without needles or expensive brain scans.

EEG electrodes attached to the back of a woman's head. Hospital environment in the background.
Photo: Science Photo Library/NTB

Forskningsartikkel av: Faculty of Technology, Art and Design (TKD)

Publisert: 08.05.2026Sist oppdatert: 12.11.2026
Olav-Johan Øye

Kort oppsummert

  • EEG measures the brain’s activity using small electrodes placed on the head.
  • The researcher has used EEG, demographic and clinical data with AI models to estimate a key blood marker (p‑tau217) that is closely linked to Alzheimer’s.
  • In time, the method could make assessment of Alzheimer’s easier and more accessible, but it must be tested in larger groups before it can be used clinically.

Short summary has partly been created using Sikt KI. The text has been quality assured by OsloMet.

These findings come from Rabindra Khadka’s doctoral work in engineering science at OsloMet.

Currently, many people undergo costly brain scans or have samples of cerebrospinal fluid taken to investigate Alzheimer’s. This can be burdensome and is not always easy to access.

The EEG brain test is already available in many hospitals and clinics; it is affordable and does not hurt. If we can detect early signs of disease using EEG, more people can receive assessment sooner.

“Our aim was to detect early dementia so that we can help these people, that is the main goal,” emphasises Rabindra Khadka.

How it works

  • EEG picks up brain activity. The AI model learns to recognise patterns linked to Alzheimer’s.
  • When EEG data are combined with simple information about the person, for example age or results from cognitive tests and other clinical information, accuracy improves.
  • The AI model first trains on large amounts of brain signals to become good at spotting patterns, and is then fine‑tuned on smaller datasets where researchers know more about the participants.
  • In addition, researchers look at short, repeating patterns in the brain signals. These can provide simple explanations that help professionals understand what the model focuses on.

“With electrodes on the head instead of needles, we get a window into the brain, how it works,” explains Khadka.

Simpler, faster and more affordable

This is the first time anyone has shown that EEG, together with demographic and clinical personal information, can estimate the level of an Alzheimer’s‑related blood marker known as p‑tau217.
A tailored AI framework has been designed to identify how brain activity evolves over time, while also explaining how it reaches its decisions.

The model has been made lighter and faster, so the analysis can in principle run on simpler equipment close to the patient.

“As far as I am aware, this is the first time anyone has tried to predict p‑tau217 from EEG. The results are preliminary, but very promising,” says Khadka.

Less burden and better access

“In practice, the patient avoids a painful process involving blood tests or spinal fluid sampling. If we can estimate the level within a certain margin of error, that is a big step forward.”

Electrodes on the head rather than needles and expensive scans can reduce the burden on patients. EEG is also widespread and can be used in more places across the health service.

“EEG is affordable, portable and can be used in many clinics and smaller hospitals, including in countries with fewer resources,” says Khadka.

“With this kind of system, doctors get an extra assistant that provides feedback based on a biomarker, without a long and expensive work‑up.”

More research is needed first

The results must be confirmed in larger and more diverse patient groups before the method can be adopted.

More standardisation is also needed. EEG measurements can differ from place to place, and quality can vary.

The next step is to show how reliable the model’s predictions are and to allow hospitals to work together to improve it, without needing to share sensitive patient data.

“A major limitation today is the amount of data. The model was trained and evaluated with limited data samples, and it included few severe dementia cases. The method needs broader testing, and we must show how reliable the estimates are,” says Khadka.

“If hospitals collect more data and we continue development, I can see a robust standard model being ready within five years.”

Privacy, with explainability

Although data in this project were processed in secure cloud services, Khadka points to solutions that can protect privacy even better.

“In future, data can be stored locally at hospitals. The model can also be sent to the hospital, trained on-site, and then returned without sharing any raw data,” he says.

“Some clinicians are sceptical of ‘black boxes’ where it is not clear how models reach their results. That is why we are working towards more transparency and explanations in the models.”

About the PhD

Rabindra Khadka completed his PhD at OsloMet’s Department of Computer Science, Faculty of Technology, Art and Design. He has developed methods that use EEG together with simple personal information to estimate Alzheimer’s‑related blood markers. The work emphasises explanations that professionals can understand and solutions that can work in practice.

Reference

Rabindra Khadka: Structured Representations for EEG‑Based Dementia Prediction. From Spatiotemporal Transformers to Multimodal Biomarker Regression. OsloMet Thesis 2026, no. 24 (nva.sikt.no).

Featured research

  • Portrait of elderly lady in bed.
    • Health and social work
    • Information systems and technology

    Using artificial intelligence to detect and fight dementia

    Dementia affects millions of people each year. It’s a problem that most of us will encounter in our lives and it does not yet have any cure or even effective early detection methods.

More featured research

Forskningsartikkel av: Faculty of Technology, Art and Design (TKD)

Publisert: 08.05.2026Sist oppdatert: 12.11.2026
Olav-Johan Øye

OSLO METROPOLITAN UNIVERSITY
STORBYUNIVERSITETET

P.O. Box 4, St. Olavs plass
NO-0130 Oslo
Norway
Tel.: +47 67 23 50 00

Contact us

  • Facebook
  • LinkedIn
  • Instagram
  • Norwegian
  • Accessibility statement
  • Cookies policy
  • Employee directory
  • Employee website
  • Student website
  • Upcoming events
  • Work for us

What are EEG and p‑tau217?

  • EEG is a test where small electrodes (sensors) are placed on the head to measure the brain’s electrical activity. It is used today in epilepsy and sleep assessments and can also provide information about brain function in dementia.
  • p-tau217 is a blood marker that often rises with Alzheimer's disease. Higher levels are linked to changes in the brain and are increasingly used as an early indicator of the disease.
Portrait of Rabindra Khadka.
Rabindra Khadka's goal is earlier and less stressful dementia diagnosis. Photo: Olav-Johan Øye